Patent US5095030A successfully refreshed from Google Patents.
US5095030A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Wavelength-specific cytotoxic agents
Assignee: University of British Columbia
•
Filing: 1989-09-28
•
Granted: 1992-03-10
•
Expires: 2009-09-28
Abstract
Abstract A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.
Inventors
- 👤 Julia G. Levy
- 👤 David Dolphin
- 👤 Jack K. Chow
- 👤 Ethan Sternberg
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 22:08
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/22; A; A61; A61K; A61K41/00; A61K41/0057; A61K41/0071; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/10; A61K51/1093; A61K2121/00
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
257 words
A compound of the formula ##STR17## or the metalated and/or labeled form thereof; wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy (2-6C), aklyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO--where R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is aklyl (1-6C); and R 4 is CHCH 2 , [CHOR 4' ,]--CH 2 OR 4' --CHO, --COOR 4' , --CH(OR 4' )CH 3 ,CH(OR 4' )CH 2 OR 4' ,--CH(SR 4' )CH 3 , --CH(NR 4' 2 ) CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 --CH((OOCR 4' )CH 3 , --CH(halo)CH 3 , or --CH(halo)CH 2 (halo), wherein R 4' is H or alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula -L-P wherein -L- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl.
Claim 2
Dependent Claim
257 words
A compound of the formula ##STR17## or the metalated and/or labeled form thereof; wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy (2-6C), aklyl (1-6C) sulfonyl, aryl (6-10C) sulfonyl, aryl (6-10C); cyano; and --CONR 5 CO--where R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is aklyl (1-6C); and R 4 is CHCH 2 , [CHOR 4' ,]--CH 2 OR 4' --CHO, --COOR 4' , --CH(OR 4' )CH 3 ,CH(OR 4' )CH 2 OR 4' ,--CH(SR 4' )CH 3 , --CH(NR 4' 2 ) CH 3 , --CH(CN)CH 3 , --CH(COOR 4' )CH 3 --CH((OOCR 4' )CH 3 , --CH(halo)CH 3 , or --CH(halo)CH 2 (halo), wherein R 4' is H or alkyl (1-6C) optionally substituted with a hydrophilic substituent, or wherein R 4 consists of 1-3 tetrapyrrole-type nuclei of the formula -L-P wherein -L- is selected from the group consisting of ##STR18## and P is selected from the group consisting of Gp which is of the formula 1-6 but lacking R 4 and conjugated through the position shown as occupied by R 4 to L, and a porphyrin of the formula: ##STR19## wherein two of the bonds shown as unoccupied on adjacent rings are joined to R 3 and one of the remaining bonds shown as unoccupied is joined to R 4 and the other to L; with the proviso that if R 4 is CHCH 2 , both R 3 cannot be carbalkoxyethyl.
Claim 3
Dependent Claim
89 words
A compound of the formula ##STR20## or the metalated and/or labeled form thereof; wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, aryl (6-10C) sulfinyl, aryl (6-10C); cyano; and --CONR 5 CO--where R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and wherein R 4 is a non-interfering organic group of <12C resulting from direct or indirect derivatization of vinyl.
Claim 4
Dependent Claim
89 words
A compound of the formula ##STR20## or the metalated and/or labeled form thereof; wherein each R 1 and R 2 is independently selected from the group consisting of carbalkoxy (2-6C), alkyl (1-6C) sulfonyl, aryl (6-10C) sulfinyl, aryl (6-10C); cyano; and --CONR 5 CO--where R 5 is aryl (6-10C) or alkyl (1-6C); each R 3 is independently carboxyalkyl (2-6C) or a salt, amide, ester or acylhydrazone thereof, or is alkyl (1-6C); and wherein R 4 is a non-interfering organic group of <12C resulting from direct or indirect derivatization of vinyl.
Claim 5
Dependent Claim
15 words
The compound of claim 1 or 2 wherein R 1 and R 2 are carbalkoxy.
Claim 6
Dependent Claim
15 words
The compound of claim 3 wherein R 3 and R 2 are carbomethoxy or carboxethoxy.
Claim 7
Dependent Claim
25 words
The compound of claim 1 or 2 wherein each R 3 is --CH 2 CH 2 COOH or a salt, amide, ester or acylhydrazone thereof.
Claim 8
Dependent Claim
23 words
The compound of claim 3 wherein each R 3 is --CH 2 CH 2 COOH or a salt, amide, ester or acylhydrazone thereof.
Claim 9
Dependent Claim
14 words
The compound of claim 1 or 2 which is of formulae 3 or 4.
Claim 10
Dependent Claim
12 words
The compound of claim 6 which is of formulae 3 or 4.
Claim 11
Dependent Claim
22 words
The compound of claim 1 or 2 wherein wherein R 4 is a group containing 1-3 tetrapyrrole-type nuclei of the formula -L-P.
Claim 12
Dependent Claim
20 words
The compound of claim 8 wherein wherein R 4 is a group containing 1-3 tetrapyrrole-type nuclei of the formula -L-P.
Claim 13
Dependent Claim
21 words
The compound of claim 1 or 2 which is selected from compounds of the formula ##STR21## wherein R is alkyl (1-6C).
Claim 14
Dependent Claim
34 words
A pharmaceutical composition which is useful in targeting specific biological material which composition comprises an effective amount of the compound of claim 1 or 2 in admixture with at least one pharmaceutically acceptable excipient.
References Cited (Backward Citations)
US2951600A
Cited
US4268947A
Cited
US4500507A
Cited
US4649151A
Cited
US4512762A
Cited
US4577636A
Cited
US4727027A
Cited
US4748120A
Cited
US4485806A
Cited
US4675338A
Cited
EP0175617B1
Cited
US4753958A
Cited
US4883790A
Cited
US4920143A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-10 | 1995-09-09 | 1996-03-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-10 | 1999-09-09 | 2000-03-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-10 | 2003-09-09 | 2004-03-10 | $7700.00 | Window Closed / Lapsed |